InvestorsHub Logo
Followers 0
Posts 758
Boards Moderated 0
Alias Born 06/29/2018

Re: Investorr post# 5154

Tuesday, 05/21/2019 9:47:37 AM

Tuesday, May 21, 2019 9:47:37 AM

Post# of 54915
No concern, in the company's best long-term interest. Operating loss increase in diagnostic/therapeutic segment is expected with ramp-up toward product launch, clinical trial work, and supporting hardware and software infrastructure.


Who needs a Barry Pirate when you can have a Beary Pirate.